Trial intelligence / Profile preview

Levetiracetam vs. Sulthiame in Children With BECTS

NCT00471744Phase 3Terminated

Sponsor
Ludwig Maximilian University of Munich
Start
Jun 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of levetiracetam in Self-limited epilepsy with centrotemporal spikes (SeLECTS), sponsored by Ludwig Maximilian University of Munich. Started Jun 2006; status: terminated.

02

Drugs

levetiracetam
03

Conditions

Self-limited epilepsy with centrotemporal spikes (SeLECTS)

Beyond the preview

Go deeper on NCT00471744.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00471744.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call